Related references
Note: Only part of the references are listed.Managing folate deficiency implies filling the gap between laboratory and clinical assessment
Simona Ferraro et al.
CLINICAL NUTRITION (2022)
A pseudo-values regression model for non-fatal event free survival in the presence of semi-competing risks
Annalisa Orenti et al.
STATISTICAL METHODS AND APPLICATIONS (2022)
Serum Prostate-Specific Antigen Testing for Early Detection of Prostate Cancer: Managing the Gap between Clinical and Laboratory Practice
Simona Ferraro et al.
CLINICAL CHEMISTRY (2021)
Laboratory medicine in the COVID-19 era: six lessons for the future
Mario Plebani
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2021)
Modelling of hypothetical SARS-CoV-2 point-of-care tests on admission to hospital from A&E: rapid cost-effectiveness analysis
Matt Stevenson et al.
HEALTH TECHNOLOGY ASSESSMENT (2021)
Prognostic biomarkers to identify patients likely to develop severe Crohn's disease: a systematic review
Steve Halligan et al.
HEALTH TECHNOLOGY ASSESSMENT (2021)
Definition of Outcome-Based Prostate-Specific Antigen (PSA) Thresholds for Advanced Prostate Cancer Risk Prediction
Simona Ferraro et al.
CANCERS (2021)
COVIDIAGNOSTIX: health technology assessment of serological tests for SARS-CoV-2 infection
Rossella Tomaiuolo et al.
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE (2021)
High-sensitivity troponin assays for early rule-out of acute myocardial infarction in people with acute chest pain: a systematic review and economic evaluation
Marie Westwood et al.
HEALTH TECHNOLOGY ASSESSMENT (2021)
Canadian cost-effectiveness model of BRCA-driven surgical prevention of breast/ovarian cancers compared to treatment if cancer develops
Manjusha Hurry et al.
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE (2020)
The new definition of health technology assessment: A milestone in international collaboration
Brian O'Rourke et al.
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE (2020)
Multi-Criteria-Decision-Analysis (MCDA) for the Horizon Scanning of Health Innovations an Application to COVID 19 Emergency
Matteo Ruggeri et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2020)
Value-based healthcare: the role of laboratory medicine
Federico Pennestri et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2019)
Perspective on Prostate Cancer Screening
Sigrid V. Carlsson et al.
CLINICAL CHEMISTRY (2019)
Making new biomarkers a reality: the case of serum human epididymis protein 4
Simona Ferraro et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2019)
Prostate-Specific Antigen-Based Screening for Prostate Cancer Evidence Report and Systematic Review for the US Preventive Services Task Force
Joshua J. Fenton et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Phase IV Studies: Some Insights, Clarifications, and Issues
Bruno Mario Cesana et al.
CURRENT CLINICAL PHARMACOLOGY (2018)
APRAISING THE APPRAISERS: DO NATIONAL HEALTH TECHNOLOGY ASESSMENT AGENCIES ( NICE, GBA/IQWIG) FOLLOW THEIR OFFICIAL EVALUATION CRITERIA?
R. Schaefer et al.
VALUE IN HEALTH (2017)
(Very) Early technology assessment and translation of predictive biomarkers in breast cancer
Anna Miquel-Cases et al.
CANCER TREATMENT REVIEWS (2017)
Overinterpretation of Research Findings: Evidence of Spin in Systematic Reviews of Diagnostic Accuracy Studies
Trevor A. McGrath et al.
CLINICAL CHEMISTRY (2017)
Waste, Leaks, and Failures in the Biomarker Pipeline
John P. A. Ioannidis et al.
CLINICAL CHEMISTRY (2017)
The side effects of translational omics: overtesting, overdiagnosis, overtreatment
Eleftherios P. Diamandis et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2016)
Description of the health problem
Geoff K. Frampton et al.
HEALTH TECHNOLOGY ASSESSMENT (2016)
Patient-Focused Benefit-Risk Analysis to Inform Regulatory Decisions: The European Union Perspective
Axel C. Muehlbacher et al.
VALUE IN HEALTH (2016)
Validation of biomarkers to predict response to immunotherapy in cancer: Volume II - clinical validation and regulatory considerations
Kevin K. Dobbin et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2016)
Letter to the editor concerning 'Do prostate cancer risk models improve the predictive accuracy of PSA screening? A meta-analysis'
S. Carlsson et al.
ANNALS OF ONCOLOGY (2015)
Adopting European Network for Health Technology Assessments (EunetHTA) core model for diagnostic technologies for improving the accuracy and appropriateness of blood gas analyzers' assessment
Tiziana Franchin et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2014)
VALUE OF DATABASES OTHER THAN MEDLINE FOR RAPID HEALTH TECHNOLOGY ASSESSMENTS
Diane L. Lorenzetti et al.
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE (2014)
RELEVANCE OF CLINICAL TRIALS TO INFORM HTA : DISPARITY BETWEN HTA EVIDENCE REQUIREMENTS AND PUBLISHED RCTS IN TYPE 2 DIABTETES MELLITUS
D. T. King et al.
VALUE IN HEALTH (2014)
HEALTH TECHNOLOGY REASSESSMENT OF NON-DRUG TECHNOLOGIES: CURRENT PRACTICES
Laura Leggett et al.
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE (2012)
A method for the early health technology assessment of novel biomarker measurement in primary prevention programs
Douwe Postmus et al.
STATISTICS IN MEDICINE (2012)
Prognostic value of cystatin C in acute coronary syndromes: enhancer of atherosclerosis and promising therapeutic target
Simona Ferraro et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2011)
Diagnostic performance of serum cobalamin tests: a systematic review and meta-analysis
Cameron D. Willis et al.
PATHOLOGY (2011)
Evaluating laboratory diagnostic tests and translational research
Mario Plebani
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2010)
Biomarkers for early detection of breast cancer: What, when, and where?
Victor V. Levenson
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2007)
Uses and abuses of tumor markers in the diagnosis, monitoring, and treatment of primary and metastatic breast cancer
N. Lynn Henry et al.
ONCOLOGIST (2006)
Share Paper
